200 related articles for article (PubMed ID: 18221218)
1. Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases.
Tarnawa I; Bölcskei H; Kocsis P
Recent Pat CNS Drug Discov; 2007 Jan; 2(1):57-78. PubMed ID: 18221218
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the medicinal chemistry of sodium channel blockers and their therapeutic potential.
Zuliani V; Patel MK; Fantini M; Rivara M
Curr Top Med Chem; 2009; 9(4):396-415. PubMed ID: 19442209
[TBL] [Abstract][Full Text] [Related]
3. Voltage-gated sodium channel blockers for the treatment of neuropathic pain.
Cummins TR; Rush AM
Expert Rev Neurother; 2007 Nov; 7(11):1597-612. PubMed ID: 17997706
[TBL] [Abstract][Full Text] [Related]
4. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.
Catterall WA; Goldin AL; Waxman SG
Pharmacol Rev; 2005 Dec; 57(4):397-409. PubMed ID: 16382098
[TBL] [Abstract][Full Text] [Related]
5. Sodium channel blockers for neuropathic pain.
Zuliani V; Rivara M; Fantini M; Costantino G
Expert Opin Ther Pat; 2010 Jun; 20(6):755-79. PubMed ID: 20384535
[TBL] [Abstract][Full Text] [Related]
6. Voltage-gated sodium channel blockers for the treatment of chronic pain.
Matulenko MA; Scanio MJ; Kort ME
Curr Top Med Chem; 2009; 9(4):362-76. PubMed ID: 19442207
[TBL] [Abstract][Full Text] [Related]
7. Voltage-gated Na+ channels in neuropathic pain.
Hargus NJ; Patel MK
Expert Opin Investig Drugs; 2007 May; 16(5):635-46. PubMed ID: 17461737
[TBL] [Abstract][Full Text] [Related]
8. Neurological perspectives on voltage-gated sodium channels.
Eijkelkamp N; Linley JE; Baker MD; Minett MS; Cregg R; Werdehausen R; Rugiero F; Wood JN
Brain; 2012 Sep; 135(Pt 9):2585-612. PubMed ID: 22961543
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology of voltage-gated sodium channels in sensory neurones.
Docherty RJ; Farmer CE
Handb Exp Pharmacol; 2009; (194):519-61. PubMed ID: 19655117
[TBL] [Abstract][Full Text] [Related]
10. Voltage-gated sodium channels in neurological disorders.
Chahine M; Chatelier A; Babich O; Krupp JJ
CNS Neurol Disord Drug Targets; 2008 Apr; 7(2):144-58. PubMed ID: 18537643
[TBL] [Abstract][Full Text] [Related]
11. Sodium channel blockers: a patent review (2010 - 2014).
Zuliani V; Rapalli A; Patel MK; Rivara M
Expert Opin Ther Pat; 2015 Mar; 25(3):279-90. PubMed ID: 25539043
[TBL] [Abstract][Full Text] [Related]
12. Sodium channels and therapy of central nervous system diseases.
Taylor CP; Narasimhan LS
Adv Pharmacol; 1997; 39():47-98. PubMed ID: 9160113
[TBL] [Abstract][Full Text] [Related]
13. Voltage-gated sodium channels and pain.
Priestley T
Curr Drug Targets CNS Neurol Disord; 2004 Dec; 3(6):441-56. PubMed ID: 15578963
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches targeting prostate cancer progression using novel voltage-gated ion channel blockers.
Sikes RA; Walls AM; Brennen WN; Anderson JD; Choudhury-Mukherjee I; Schenck HA; Brown ML
Clin Prostate Cancer; 2003 Dec; 2(3):181-7. PubMed ID: 15040863
[TBL] [Abstract][Full Text] [Related]
15. The role of sodium channels in neuropathic pain.
Rogers M; Tang L; Madge DJ; Stevens EB
Semin Cell Dev Biol; 2006 Oct; 17(5):571-81. PubMed ID: 17123847
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of sodium channel gating by trapping the domain II voltage sensor with protoxin II.
Sokolov S; Kraus RL; Scheuer T; Catterall WA
Mol Pharmacol; 2008 Mar; 73(3):1020-8. PubMed ID: 18156314
[TBL] [Abstract][Full Text] [Related]
17. Molecular properties of brain sodium channels: an important target for anticonvulsant drugs.
Catterall WA
Adv Neurol; 1999; 79():441-56. PubMed ID: 10514834
[TBL] [Abstract][Full Text] [Related]
18. The role of sodium channels in chronic inflammatory and neuropathic pain.
Amir R; Argoff CE; Bennett GJ; Cummins TR; Durieux ME; Gerner P; Gold MS; Porreca F; Strichartz GR
J Pain; 2006 May; 7(5 Suppl 3):S1-29. PubMed ID: 16632328
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs.
Vohora D; Saraogi P; Yazdani MA; Bhowmik M; Khanam R; Pillai KK
Drugs Today (Barc); 2010 Apr; 46(4):265-77. PubMed ID: 20502724
[TBL] [Abstract][Full Text] [Related]
20. Potassium channel blockers and openers as CNS neurologic therapeutic agents.
Judge SI; Smith PJ; Stewart PE; Bever CT
Recent Pat CNS Drug Discov; 2007 Nov; 2(3):200-28. PubMed ID: 18221232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
